In vivo anticlastogenic effects of L-ascorbic acid in mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 438, Issue 1, 1999, Pages 47-51

  Vijayalaxmi, K K ^a   Venu, R ^a  

^a MANGALORE UNIVERSITY   (India)

Author keywords

Anticlastogenicity; Ascorbic acid; Bone marrow micronucleus test

Indexed keywords

ASCORBIC ACID; BLEOMYCIN; CYCLOPHOSPHAMIDE; MITOMYCIN C; MUTAGENIC AGENT;

ANIMAL MODEL; ARTICLE; BONE MARROW TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMUTAGENIC AGENTS; ASCORBIC ACID; BLEOMYCIN; BONE MARROW; CYCLOPHOSPHAMIDE; FEMALE; MALE; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MITOMYCIN; MUTAGENICITY TESTS; MUTAGENS;

EID: 0032903227     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00161-2     Document Type: Article

References (26)

1. Ferguson L.R. Antimutagens as cancer chemopreventive agents in the diet. Mutation Res. 307:1994;395-410.
2. Chatterjee I.B., Mukhopadhyay C.K., Ghosh M.K. Vitamin C: a potential saviour against free radical induced oxidative damage. Current Science. 69(9):1995;747-751.
3. Singh V.N., Gaby S. Premalignant lesions, role of antioxidant vitamins and B-carotene in risk reduction and prevention of malignant transformation. Am. J. Clin. Nutr. 53:1991;386S-390S.
4. Lin X., Sugiyama M., Costa M. Differences in the effect of vitamin-E on nickel sulfide or nickel chloride induced chromosomal aberrations in mammalian cells. Mutation Res. 260:1991;159-164.
5. Mukherjee A., Agarwal S.K., Aguilar M.A., Sharma A. Anticlastogenic activity of B-carotene against cyclophosphamide in mice in vivo. Mutation Res. 263:1991;41-46.
6. Hoda Q., Sinha S.P. Vitamin-C mediated minimisation of rogor induced genotoxicity. Mutation Res. 229:1993;29-36.
7. Khan P.K., Sinha S.P. Antimutagenic efficacy of higher doses of vitamin-C. Mutation Res. 298:1993;157-161.
8. Ghaskadbi S., Vaidya V.G. In vivo antimutagenic effect of ascorbic acid against the mutagenicity of the common antiamoebic drug diiodohydroxyquinoline. Mutation Res. 222:1989;219-222.
9. Kojima H., Konishi H., Kuroda Y. Effects of L-ascorbic acid on the mutagenicity of ethlymethane sulfonate in cultured mammalian cells. Mutation Res. 266:1992;85-91.
10. Dhir H., Roy A.K., Sharma A. Relative efficiency of Phyllanthus emblica fruit extract and ascorbic acid in modifying lead and aluminium induced sister-chromatid exchanges in mouse bone marrow. Environ. Mol. Mutagenesis. 21:1993;229-236.
11. Martindale, in: E.F. Reynolds, A.B. Prasad (Eds.), The Extrapharmacopoeia, 28th edn., The Pharmaceutical Press, London (1982).
12. Schmid W. Chemical mutagens testing on in vivo somatic mammalian cells. Agents Action. 3:1973;77-85.
13. K.P. Seetharama Rao, M. Abdul Rahiman, S.P. Koranne, Bovine albumin as a substitute for fetal calf serum in the micronucleus test, Int. Symp. on Recent Trends in Med. Genet. 28 (1983).
14. T.H. Hassard, Understanding Biostatistics, Mosby year book, St. Louis (1991).
15. Matter B.E., Grauwiler J. Micronuclei in mouse bone marrow cells. A simple in vivo model for the evaluation of drug-induced chromosomal aberrations. Mutation Res. 23:1974;239-249.
16. Salamone M., Heddle J., Stuart E., Katz M. Towards an improved micronucleus test, studies on 3 model agents, mitomycin-C, cyclophosphamide and dimethylbezanthracene. Mutation Res. 74:1980;347-356.
17. Erexson G.L., Bryant M.F., Kwanyuen P., Kligeman A.D. Bleomycin sulfate-induced micronuclei in human, rat, and mouse peripheral blood lymphocytes. Environ. Molecular Mutagenesis. 25:1995;31-36.
18. Ghaskadbi S., Rajamachikar S., Agate C., Kapadi A.H., Vaidya V.G. Modulation of cyclophosphamide mutagenicity by vitamin-C in the in vivo rodent micronuclei assay. Terato. Carcino. Mutagen. 12:1992;11-17.
19. Krishna G., Nath J., Ong T. Inhibition of cyclophosphamide and mitomycin-C induced sister chromatid exchanges in mice by vitamin-C. Cancer Res. 46:1986;2670-2674.
20. Edgar J.A. Ascorbic acid and biological alkylating agents. Nature. 248:1974;136-137.
21. Povirk L.F., Austin M.J.F. Genotoxicity of bleomycin. Mutation Res. 257:1991;127-143.
22. Cunningham M.L., Ringrose P.S., Likesh B.R. Inhibition of the genotoxicity of bleomycin by superoxide dismutase. Mutation Res. 135:1984;199-202.
23. Anderson D., Basaran N., Blowers S.D., Edwards A.J. The effect of antioxidants on bleomycin treatment in, in vitro and in vivo genotoxicity assays. Mutation Res. 329:1995;37-47.
24. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutation Res. 147:1985;29-36.
25. Fenech M., Morley A.A. Cytokinesis-block micronucleus method in human lymphocytes: effects of in vivo ageing and low dose X-irradiation. Mutation Res. 161:1986;193-198.
26. Uma Devi P., Satish Rao B.S., Kamath R. A method to score micronuclei in vivo using cytochalasin-B induced cytokinesis block. Mutation Res. 401:1998;33-37.